The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Concurrence of Malignant Peripheral Nerve Sheath Tumor at the Site of Complex Regional Pain Syndrome Type 1 - A Case Report -

  • Jeong, Yeong Ho (Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital) ;
  • Choi, Eun Joo (Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital) ;
  • Nahm, Francis Sahngun (Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital)
  • Received : 2012.10.25
  • Accepted : 2012.12.21
  • Published : 2013.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are very rare sarcomas derived from various cells in the peripheral nerve sheath. Malignant peripheral nerve sheath tumors have a known association with neurofibromatosis type 1. Diagnosis of MPNSTs is difficult in patients with chronic pain, when MPNST occurs at an overlapping area of chronic pain. Therefore, the diagnosis can be missed unless clinicians pay attention to the possibility of this disease. Here in, we report a case of concurrent malignant peripheral nerve sheath tumor with complex regional pain syndrome type 1. A 44-year female patient, who was diagnosed with complex regional pain syndrome (CRPS) type 1 in her left ankle, visited our clinic because of aggravated pain. The cause of the aggravated pain was revealed as concurrent MPNST in the left common peroneal nerve territory, which overlapped the site of pain from CRPS.

Keywords

References

  1. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986; 57: 2006-2021. https://doi.org/10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6
  2. Sordillo PP, Helson L, Hajdu SI, Magill GB, Kosloff C, Golbey RB, et al. Malignant schwannoma--clinical characteristics, survival, and response to therapy. Cancer 1981; 47: 2503-2509. https://doi.org/10.1002/1097-0142(19810515)47:10<2503::AID-CNCR2820471033>3.0.CO;2-3
  3. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 2002; 62: 1573-1577.
  4. Hrehorovich PA, Franke HR, Maximin S, Caracta P. Malignant peripheral nerve sheath tumor. Radiographics 2003; 23: 790-794. https://doi.org/10.1148/rg.233025153
  5. Perrin RG, Guha A. Malignant peripheral nerve sheath tumors. Neurosurg Clin N Am 2004; 15: 203-216. https://doi.org/10.1016/j.nec.2004.02.004
  6. Adamson DC, Cummings TJ, Friedman AH. Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin's lymphoma. Clin Neuropathol 2004; 23: 245-255.
  7. Amin A, Saifuddin A, Flanagan A, Patterson D, Lehovsky J. Radiotherapy-induced malignant peripheral nerve sheath tumor of the cauda equina. Spine 2004; 29: E506-E509. https://doi.org/10.1097/01.brs.0000143168.87295.ca
  8. Bhattacharyya AK, Perrin R, Guha A. Peripheral nerve tumors: management strategies and molecular insights. J Neurooncol 2004; 69: 335-349. https://doi.org/10.1023/B:NEON.0000041891.39474.cb
  9. Vauthey JN, Woodruff JM, Brennan MF. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience. Ann Surg Oncol 1995; 2: 126-131. https://doi.org/10.1007/BF02303627
  10. Baehring JM, Betensky RA, Batchelor TT. Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology 2003; 61: 696-698. https://doi.org/10.1212/01.WNL.0000078813.05925.2C
  11. Koea JB, Leung D, Lewis JJ, Brennan MF. Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity? Ann Surg Oncol 2003; 10: 432-440. https://doi.org/10.1245/ASO.2003.05.014
  12. Storm FK, Eilber FR, Mirra J, Morton DL. Neurofibrosarcoma. Cancer 1980; 45: 126-129. https://doi.org/10.1002/1097-0142(19800101)45:1<126::AID-CNCR2820450122>3.0.CO;2-U
  13. Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer 1990; 66: 1253-1265. https://doi.org/10.1002/1097-0142(19900915)66:6<1253::AID-CNCR2820660627>3.0.CO;2-R
  14. Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer 2006; 107: 1065-1074. https://doi.org/10.1002/cncr.22098
  15. Doorn PF, Molenaar WM, Buter J, Hoekstra HJ. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 1995; 21: 78-82. https://doi.org/10.1016/S0748-7983(05)80073-3
  16. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer 1993; 71: 1247-1253. https://doi.org/10.1002/1097-0142(19930215)71:4<1247::AID-CNCR2820710413>3.0.CO;2-S
  17. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 1998; 42: 351-360.
  18. Garg A, Gupta V, Gaikwad SB, Mishra NK, Ojha BK, Chugh M, et al. Scalp malignant peripheral nerve sheath tumor (MPNST) with bony involvement and new bone formation: case report. Clin Neurol Neurosurg 2004; 106: 340-344. https://doi.org/10.1016/j.clineuro.2004.01.003

Cited by

  1. Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis vol.154, pp.2, 2021, https://doi.org/10.1007/s11060-021-03826-3